Effects of a low-FODMAP enteral formula on gastrointestinal complications on patients in the intensive care unit

Bundang CHA General Hospital0 个研究点目标入组 84 人开始时间: 待定最近更新: 2021年1月6日

适应症

试验速览

暂无简介。

•The subjects were adult patients over 18 years of age, who entered the ICU and who were initiated on EN support through standard formulations and not special formulations (such as diabetes/kidney/concentration/high protein formulations). Since the subjects were not conscious enough to provide consent for the study, we explained and obtained the consent from the legal guardians. The patients who were diagnosed with underlying diseases like diabetes, kidney diseases, digestive diseases, and infectious diseases, and were on medication for the related diseases in the last 6 months were excluded. Patients who were being administered proton pump inhibitors (PPI), antibiotics except ß-latamase, antifungal agents, and laxatives were excluded.

•The subjects were adult patients over 18 years of age, who entered the ICU and who were initiated on EN support through standard formulations and not special formulations (such as diabetes/kidney/concentration/high protein formulations). Since the subjects were not conscious enough to provide consent for the study, we explained and obtained the consent from the legal guardians. The patients who were diagnosed with underlying diseases like diabetes, kidney diseases, digestive diseases, and infectious diseases, and were on medication for the related diseases in the last 6 months were excluded. Patients who were being administered proton pump inhibitors (PPI), antibiotics except ß-latamase, antifungal agents, and laxatives were excluded.

发起方

Bundang CHA General Hospital